Stay updated on Safety of PBCAR20A in NHL/CLL Clinical Trial
Sign up to get notified when there's something new on the Safety of PBCAR20A in NHL/CLL Clinical Trial page.

Latest updates to the Safety of PBCAR20A in NHL/CLL Clinical Trial page
- Check6 days agoChange DetectedA 403 Forbidden error page is now shown instead of the study details, indicating an access issue rather than new or updated study information.SummaryDifference20%

- Check13 days agoChange DetectedRevision tag updated from v3.6.6 to v3.7.0. This update reflects an internal version bump rather than changes to the study content or user-facing information.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page revision was updated from v3.6.5 to v3.6.6, representing a small update to the study record rather than a substantive change to the study details.SummaryDifference0.1%

- Check48 days agoChange DetectedThe page's revision label was updated from v3.6.4 to v3.6.5. This is a metadata/version update.SummaryDifference0.0%

- Check62 days agoChange DetectedThe page now lists Revision: v3.6.4, signaling an administrative update to the study page. The previous Revision: v3.6.3 label appears to have been removed.SummaryDifference0.0%

- Check84 days agoChange DetectedThe page now shows Revision: v3.6.3, indicating a new version of the page has been published. This update pertains to the revision history and does not alter the study details.SummaryDifference0.0%

Stay in the know with updates to Safety of PBCAR20A in NHL/CLL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of PBCAR20A in NHL/CLL Clinical Trial page.